Photostabilization of retinoids with alkoxycrylene compounds
View Patent ↗The photostabilizing electronic excited state energy—particularly singlet state energy from retinoid compounds—has been found to be readily transferred to (accepted by) α-cyanodiphenylacrylate compounds having an alkoxy radical in the four (para) position (hereinafter “alkoxycrylenes”) on one of the phenyl rings having the formula (I): wherein one of R 1 and R 2 is a straight or branched chain C 1 -C 30 alkoxy radical, preferably C 1 -C 8 , more preferably methoxy, and the non-alkoxy radical R 1 or R 2 is hydrogen; and R 3 is a straight or branched chain C 1 -C 30 alkyl radical, preferably C 2 -C 20 . The alkoxycrylene compounds of formula (I) significantly increase the photostability of retinoid compounds in a composition by at least 3-fold and as much as 10-fold or greater. The ability of the alkoxycrylene compounds to stabilize the retinoid compound is concentration dependent, with the amount of retinoid photostabilization increasing with the concentration of the alkoxycrylene compound.
1. A method of protecting a retinoid compound in a sunscreen or dermatological composition that reaches a singlet excited state or fluoresces when exposed to UV radiation from UV-induced photodegradation comprising combining the retinoid compound with a compound of formula (I) in an amount of at least 0.1%, based on the total weight of the composition, to quench singlet excited state energy from the retinoid compound and transfer the singlet excited state energy from the retinoid compound to the compound of formula (I),
wherein one of R 1 and R 2 is a straight or branched chain C 1 -C 30 alkoxy radical, and the non-alkoxy R 1 or R 2 is hydrogen; and R 3 is a straight or branched chain C 1 -C 30 alkyl radical, thereby photostabilizing the retinoid compound.
2. The method of claim 1 , wherein R 1 is methoxy and R 2 is hydrogen.
3. The method of claim 1 , wherein R 1 is hydrogen and R 2 is methoxy.
4. The method of claim 1 , wherein R 3 is a C 12 -C 24 straight chain or branched alkyl.
5. The method of claim 4 , wherein R 3 is a 2-butyloctyl radical.
6. The method of claim 4 , wherein R 3 is an 2-ethylhexyl radical.
7. The method of claim 1 , wherein the compound of formula (I) is present in an amount in the weight range of about 0.1% to about 20%, based on the total weight of the composition.
8. The method of claim 7 , wherein the compound of formula (I) is present in an amount in this weight range of about 0.1% to about 10%, based on the total weight of the composition.
9. The method of claim 7 , wherein the compound of formula (I) is present in an amount in this weight range of about 0.1% to about 5%, based on the total weight of the composition.
10. The method of claim 1 , wherein the retinoid compound is present in an amount in the weight range of about 0.001% to about 5%, based on the total weight of the composition.
11. The method of claim 10 , wherein the retinoid compound is present in this weight range of about 0.005% to about 1%, based on the total weight of the composition.
12. The method of claim 10 , wherein the retinoid compound is present in this weight range of about 0.01% to about 0.5%, based on the total weight of the composition.
13. The method of claim 1 , wherein a molar ratio of the retinoid compound to the compound of formula (I) is about 0.001 to about 1.
14. The method of claim 13 , wherein the molar ratio of the retinoid compound to the compound of formula (I) is about 0.005 to about 0.1.
15. The method of claim 13 , wherein the molar ratio of the retinoid compound to the compound of formula (I) is about 0.01 to about 0.06.
16. The method of claim 1 , wherein the retinoid compound is selected from the group consisting of retinol, retinal, tretinoin, isotretinoin, alitretinoin, etretinate, and acitretin.
17. The method of claim 16 , wherein the retinoid compound is retinol.
18. The method of claim 16 , wherein the retinoid compound is isotretinoin.
19. The method of claim 16 , wherein the retinoid compound is tretinoin.
20. The method of claim 16 , wherein the retinoid compound is retinal.
21. The method of claim 16 , wherein the retinoid compound is alitretinoin.
22. The method of claim 16 , wherein the retinoid compound is etretinate.
23. The method of claim 16 , wherein the retinoid compound is acitretin.
24. The method of claim 1 , wherein said composition further comprises a lipophilic active compound in an amount of about 0.001 wt % to about 10 wt %, based on the total weight of the composition.
25. The method of claim 24 , wherein the lipophilic active compound is in an amount of about 0.001 wt % to about 5 wt %, based on the total weight of the composition.
26. The method of claim 24 , wherein the lipophilic active compound is selected from the group consisting of ubiquinones and plastoquinones.
27. The method of claim 24 , wherein the lipophilic active compound is coenzyme Q10.
28. The method of claim 1 , wherein the retinoid compound is an ester of retinoic acid.
29. The method of claim 1 , wherein the retinoid compound is bexarotene.
30. The method of claim 1 , wherein the retinoid compound is tazarotene.
31. The method of claim 1 , wherein the retinoid compound is adapalene.